Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis

Gail P. Risbridger, Damien Bolton, David Clouston et al.|European Urology|2014

Cited by 137